NCT05235906 2023-08-09
A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer
Sun Yat-sen University
Phase 2 Unknown
Sun Yat-sen University
Shanghai University of Traditional Chinese Medicine
Assiut University
Yonsei University
Chinese PLA General Hospital